Prosetta Biosciences Inc

Unlocking Protein Assemblies. Redefining Drug Discovery. Prosetta Biosciences is pioneering small-molecule drug discovery through the Prosetta Paradigm, a breakthrough approach that targets protein assemblies, an overlooked layer of biology in pharmaceutical research. This innovation has already generated first-in-class and best-in-class molecules with potential to address some of the world’s toughest health challenges, including: • Infectious Diseases – pan-family antivirals, antifungals, and next-generation antibiotics for antimicrobial resistance (AMR). • Oncology – small molecules targeting malignant cancers and inflammation. • Neurodegeneration – novel drug candidates designed to slow or halt disease progression. With research anchored in the United States and discovery expanded through our wholly owned subsidiary, Prosetta Bioconformatics (India), we combine cutting-edge science with global execution. Our mission: to uncover hidden biological pathways and create transformative medicines that redefine the future of biotechnology and global health.